Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Screening For BCRL In Targeted Therapy For Breast Cancer

NCT: NCT05142800 · RECRUITING

NCT IDNCT05142800
StatusRECRUITING
Start Date2018-12-13
Completion2026-09-30
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

This a prospective, longitudinal study designed to track edema and Breast Cancer Related Lymphedema (BCRL) onset in breast cancer patients taking targeted therapy treatments for early and metastatic breast cancer. A Perometer and Sozo devise will be used to measure volume changes

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑